Clinics tend to price peptide programs one of two ways: copy what the practice down the road charges, or apply a flat multiple to the invoice. Both leave money on the table, and the second one loses money on some products without anyone noticing.
Here is a more deliberate way to think about it.
Start with landed cost, not invoice cost
Your real cost per vial is not the line on the invoice. It includes:
- The unit price
- Shipping, allocated across the order
- Any cold-chain or handling surcharge
- The carrying cost of inventory that sits before it moves
- An allowance for waste — expiry, breakage, and returns
Landed cost is usually 8–15% above invoice cost on a typical order, and considerably more on small, frequent orders. That gap is the single most common reason a program that looks profitable on paper isn't.
Order size moves your cost more than negotiation does
Wholesale peptide pricing is tiered. The step from a small order to the next tier often moves unit cost more than any amount of haggling will.
But tier chasing has a limit. Buying up a tier only helps if the product actually moves before it expires. A 20% better unit price on stock that sits for eight months is not a saving.
Price per product, not per catalog
A flat multiple across every product is the mistake that quietly costs the most. Products differ in:
- How fast they move
- How much cold storage they occupy
- Shelf life, and therefore waste risk
- How price-sensitive the buyer is
A fast-moving, long-shelf-life product can carry a thinner margin because volume covers it. A slow, short-dated product needs a thicker one because some of it will be written off.
Build the write-off into the price
If historically you discard 5% of a given product to expiry, that 5% has to live somewhere. It either comes out of margin silently, or it goes into the price deliberately. Deliberately is better.
Revisit pricing on a schedule
Wholesale costs move. Clinics that set prices once and revisit them annually spend most of the year mispriced.
A quarterly review is enough. Look at what actually moved, what was written off, and where landed cost has drifted. Inventory planning pairs directly with this — your reorder data is your pricing data.
Watch the products you're subsidising
Run the margin per product, not just program-wide. Most clinics find one or two products are effectively subsidised by the rest — usually something ordered in small quantities at a poor tier, priced by habit rather than cost.
Those are the ones to either reprice, order differently, or stop carrying.
A note on white-label
If you are labelling under your own brand, the labelling cost belongs in landed cost too. It is usually modest per unit at volume and meaningful at low volume. White-label peptides for clinics covers how that works.
Where AA LABS fits
We publish clear tiered wholesale pricing to verified clinic accounts, so you can model landed cost before you commit rather than after. If you want help working out what your real cost per unit is across a proposed order, ask — it is a short conversation and it usually changes what people order.